Finally, the performance of the different analytical strategies was compared in patients with both CLPD-NK and NK-cell lymphocytosis highly suspected of being clonal, in which loss of CD16 and CD56 has been recurrently reported as a frequently tumor-associated aberrant phenotype (14, 15, 54–57). This evidence concerns the gene NCAM1 and neoplasm.